Contact, Help, Advice and Information Network (CHAIN) is an online mutual support network for people working in health and social care. It gives people a simple and informal way of contacting each other to exchange ideas and share knowledge.
The aim of the CHAIN dementia sub-group, of which Alzheimer's Society is the stake-holder, is to enable those with an interest in dementia care and research to connect and share knowledge and expertise.
Written by Lakshini Mendis on Wednesday September 5, 2018
dementia, carehome, alzheimers
In order to improve care for people living with dementia, Alzheimer’s Society is committed to funding care research, as well as supporting the translation of research into practice to help close the gap between the production and utilisation of knowledge.
Alzheimer's Society is currently scoping ideas for the launch of a funding call later this year, to explore different models for enabling enhanced care provider roles in research, in order to facilitate successful implementation.
Buprenorphine transdermal system is increasingly prescribed for people with advanced dementia. However, little is known about the potential adverse effects, such as nausea, sedation, or confusion, in people living with moderate to severe dementia and depressive symptoms in care homes.
This gap was addressed by the DEP.PAIN.DEM trial, which was funded by the Research Council of Norway and conducted by the Centre for Elderly and Nursing Home Medicine, University of Bergen.
New study aims to assess whether a medication called Guanfacine can improve thinking, in people with Alzheimer’s Disease.
Vitamin B can help to improve learning and memory in older people who have high levels of omega-3 fatty acids in their blood, according to new research.